Abstract
The purpose of this study was to characterise a benign pattern of infradiaphragmatic 18F-fluorodeoxyglucose (FDG) uptake in cancer patients using PET/CT. Infradiaphragmatic foci of FDG uptake, localised by PET/CT in regions of normal fat tissues, were demonstrated, in conjunction with fatty uptake in the neck and shoulders, in 9 of 1,241 (0.7%) patients. The imaging and clinical characteristics of this pattern and its possible clinical significance were assessed. PET/CT precisely localised infradiaphragmatic fat uptake (IDFU) within normal retroperitoneal fatty tissue of the perirenal space (nine patients) and in the paracolic or parahepatic space (four patients). Perirenal uptake was bilateral in five patients and focal in six. Paracolic and parahepatic uptake was bilateral in three patients and linear in all four patients. There was no evidence of malignancy at any of the sites during a follow-up period of 9–21 months. IDFU was significantly more prevalent in young patients assessed for monitoring response to therapy, and was always associated with the benign supradiaphragmatic uptake pattern, although its prevalence was significantly lower. There were no significant differences between the clinical characteristics of these two patterns of benign fatty FDG uptake. It is concluded that PET/CT allows for precise identification of increased FDG uptake in abdominal fatty tissue and further exclusion of disease at such sites. This benign uptake may represent increased glucose consumption in activated brown adipose tissue, similar to the mechanism suggested for supradiaphragmatic uptake. Recognition of this benign IDFU pattern is important for correct interpretation of abdominal PET findings in cancer patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30:150–185.
Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26:308–314.
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61–77.
Beyer T, Townsend DW, Brun T, et al. A comined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369–1379.
Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 2001; 31:191–205.
Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44:1200–1209.
Hany TF, Gharehapagh E, Kamel EM, et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002; 29:1393–1398.
Cohade C, Osman M, Pannu HK, et al. Uptake in supraclavicular area fat (“USA-Fat”): description on18F-FDG PET/CT. J Nucl Med 2003; 44:170–176.
Bar-Shalom R. Muscle uptake of 18-fluorine fluorodeoxyglucose. Semin Nucl Med 2000; 30:306–309.
Engel H, Steinert H, Buck A, et al. Whole body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37:441–446.
Stokkel MPM, Bongers V, Hordijk GL, et al. FDG positron emission tomography in head and neck cancer. Pitfall or pathology? Clin Nucl Med 1999; 24:950–954.
Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996; 37:1127–1129.
Abdel-Dayem HM, Naddaf S, El-Zeftawy H. F-18 FDG gastric and anterior abdominal muscle uptake secondary to nausea and vomiting. Clin Nucl Med 1998; 23:769–770.
Schaffler GJ, Groell R, Schoellnast H, et al. Digital image fusion of CT and PET data sets—clinical value in abdominal/pelvic malignancies. J Comput Assist Tomogr 2000; 24:644–647.
Goerres GH, Kamel E, Heidelberg T-NH, Schwitter MR, Burger C, von Schulthess GK. PET-CT image coregistration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 2002; 29:351–360.
Nakamoto Y, Tatsumi M, Cohade C, Osman M, Marshall LT, Wahl R. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging 2003; 30:597–602.
Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003; 30:588–596.
Penicaud L, Cousin B, Leloup C, et al. The autonomic nervous system, adipose tissue plasticity, and energy balance. Nutrition 2000; 16:903–908.
Santos GC, Araujo MR, Silveira TC, et al. Accumulation of brown adipose tissue and nutritional status. A prospective study of 366 consecutive autopsies. Arch Pathol Lab Med 1992; 116:1152–1154.
Heaton JM. The distribution of brown adipose tissue in the human. J Anat 1972; 112:35–39.
Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979; 281:31–35.
Lever JD, Jung RT, Nnodim JO, Leslie PJ, Symons D. Demonstration of a catecholaminergic innervation in human perirenal brown adipose tissue at various ages in adults. Anat Rec 1986; 215:251–255.
Acknowledgement
The authors thank Drs. A. Tamir, A. Frenkel and J.A. Parker for their useful assistance and Mrs. M. Perlmutter for her help in the preparation of this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bar-Shalom, R., Gaitini, D., Keidar, Z. et al. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31, 1105–1113 (2004). https://doi.org/10.1007/s00259-004-1506-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-004-1506-0